Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioStar files for rapid influenza test:

This article was originally published in Clinica

Executive Summary

US firm BioStar has filed a 510(k) application with the FDA to market a rapid diagnostic for influenza which detects two types of the virus (A and B) simultaneously. Developed with Australian firm Biota Holdings, the test takes around 15 minutes to perform and needs no instrumentation. Boulder, Colorado-based BioStar said sales will be limited until the launch of Biota's anti-flu drug Relenza.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081462

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel